ClinVar Miner

Submissions for variant NM_000178.4(GSS):c.-9+5G>A (rs1555889738)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000587316 SCV000695767 pathogenic Gluthathione synthetase deficiency 2017-04-13 criteria provided, single submitter clinical testing Variant summary: The GSS c.-9+5G>A variant involves the alteration of a conserved nucleotide in the intron that resides in the 5'UTR of the gene. One in silico tool predicts a damaging outcome for this variant. 2/5 splice prediction tools predict a significant impact on normal splicing, while ESE finder predicts that this variant does not significantly impact ESE sites at the locus. However, these predictions have yet to be confirmed by functional studies. One publication studied 41 patients with glutathione synthetase (GS) deficiency and found 3 patients who were homozygous for the variant of interest, each of whom had ~10% or less of normal GS activity levels in their cultured fibroblasts (Njalsson_Hum Genet_2005). In each case, the alleles were inherited from heterozygous parents. This variant is absent in the large control database ExAC (0/107328 control chromosomes) as well as ClinVar. Taken together, this variant is classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.